BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 19423181)

  • 1. Denial and physical outcomes in lung cancer patients, a longitudinal study.
    Vos MS; Putter H; van Houwelingen HC; de Haes HC
    Lung Cancer; 2010 Feb; 67(2):237-43. PubMed ID: 19423181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Denial and social and emotional outcomes in lung cancer patients: the protective effect of denial.
    Vos MS; Putter H; van Houwelingen HC; de Haes HC
    Lung Cancer; 2011 Apr; 72(1):119-24. PubMed ID: 20705356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Denial in lung cancer patients: a longitudinal study.
    Vos MS; Putter H; van Houwelingen HC; de Haes HC
    Psychooncology; 2008 Dec; 17(12):1163-71. PubMed ID: 18823062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The denial of cancer interview: development and first assessment of psychometric properties in lung cancer patients.
    Vos MS; Putter H; Leurs A; Rooijmans HG; de Haes HC; van Houwelingen HC
    Patient Educ Couns; 2007 Jul; 67(1-2):224-34. PubMed ID: 17498908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of pain severity on health-related quality of life: a study of Chinese cancer patients.
    Wang XS; Cleeland CS; Mendoza TR; Engstrom MC; Liu S; Xu G; Hao X; Wang Y; Ren XS
    Cancer; 1999 Nov; 86(9):1848-55. PubMed ID: 10547560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ['Doctor, I don't want to know that'--exploring denial in patients with lung cancer].
    Vos MS; Berendsen HH
    Ned Tijdschr Geneeskd; 2001 Dec; 145(50):2409-12. PubMed ID: 11776664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Joint analysis of multiple longitudinal outcomes: application of a latent class model.
    Putter H; Vos T; de Haes H; van Houwelingen H
    Stat Med; 2008 Dec; 27(29):6228-49. PubMed ID: 18816496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life measures (EORTC QLQ-C30 and SF-36) as predictors of survival in palliative colorectal and lung cancer patients.
    Grande GE; Farquhar MC; Barclay SI; Todd CJ
    Palliat Support Care; 2009 Sep; 7(3):289-97. PubMed ID: 19788770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Denial in cancer patients, an explorative review.
    Vos MS; de Haes JC
    Psychooncology; 2007 Jan; 16(1):12-25. PubMed ID: 16868929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptom prevalence, intensity, and distress in patients with inoperable lung cancer in relation to time of death.
    Tishelman C; Petersson LM; Degner LF; Sprangers MA
    J Clin Oncol; 2007 Dec; 25(34):5381-9. PubMed ID: 18048819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Framing the onset of lung cancer biographically: narratives of continuity and disruption.
    Leveälahti H; Tishelman C; Ohlén J
    Psychooncology; 2007 May; 16(5):466-73. PubMed ID: 16915570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is late diagnosis of lung cancer inevitable? Interview study of patients' recollections of symptoms before diagnosis.
    Corner J; Hopkinson J; Fitzsimmons D; Barclay S; Muers M
    Thorax; 2005 Apr; 60(4):314-9. PubMed ID: 15790987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early change in patient-reported health during lung cancer chemotherapy predicts clinical outcomes beyond those predicted by baseline report: results from Eastern Cooperative Oncology Group Study 5592.
    Eton DT; Fairclough DL; Cella D; Yount SE; Bonomi P; Johnson DH;
    J Clin Oncol; 2003 Apr; 21(8):1536-43. PubMed ID: 12697878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intervention to improve psychological functioning for newly diagnosed patients with cancer.
    Rawl SM; Given BA; Given CW; Champion VL; Kozachik SL; Kozachik SL; Barton D; Emsley CL; Williams SD
    Oncol Nurs Forum; 2002 Jul; 29(6):967-75. PubMed ID: 12096294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal study of depressive symptoms in patients with metastatic gastrointestinal and lung cancer.
    Lo C; Zimmermann C; Rydall A; Walsh A; Jones JM; Moore MJ; Shepherd FA; Gagliese L; Rodin G
    J Clin Oncol; 2010 Jun; 28(18):3084-9. PubMed ID: 20479397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How well do medical oncologists' perceptions reflect their patients' reported physical and psychosocial problems? Data from a survey of five oncologists.
    Newell S; Sanson-Fisher RW; Girgis A; Bonaventura A
    Cancer; 1998 Oct; 83(8):1640-51. PubMed ID: 9781960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HRQoL changes, mood disorders and satisfaction after treatment in an unselected population of patients with lung cancer.
    Rolke HB; Bakke PS; Gallefoss F
    Clin Respir J; 2010 Jul; 4(3):168-75. PubMed ID: 20565496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinically meaningful differences in patient-reported outcomes with amifostine in combination with chemoradiation for locally advanced non-small-cell lung cancer: an analysis of RTOG 9801.
    Sarna L; Swann S; Langer C; Werner-Wasik M; Nicolaou N; Komaki R; Machtay M; Byhardt R; Wasserman T; Movsas B
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1378-84. PubMed ID: 18501528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'A little bitty spot and I'm a big man': patients' perspectives on refusing diagnosis or treatment for lung cancer.
    Sharf BF; Stelljes LA; Gordon HS
    Psychooncology; 2005 Aug; 14(8):636-46. PubMed ID: 15744761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of physical functioning among patients with cancer: a longitudinal view.
    Kurtz ME; Kurtz JC; Given CW; Given B
    Cancer Pract; 1993; 1(4):275-81. PubMed ID: 8111437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.